Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06933290 · ClinicalTrials.gov registry record · NA
Effect of Flavored, Carbonated Drinks on Salivary Flow, Salivary Composition, and Taste Perceptions
A NA study of Taste Perception and Saliva Production, sponsored by PepsiCo Global R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT06933290: Recruiting NA study of Taste Perception and Saliva Production, sponsored by PepsiCo Global R&D.
NCT06933290 is a NA study of Taste Perception and Saliva Production that is actively recruiting participants, run by PepsiCo Global R&D. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06933290, a NA study of Taste Perception and Saliva Production, is actively recruiting participants, sponsored by PepsiCo Global R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effect of flavored, carbonated drinks on salivary flow rate, saliva composition, and taste perceptions compared with control drinks (water, carbonated water, non-carbonated)
Primary Outcome
5 minute passive drool saliva and 10 minute filter paper saliva (one sample each from tongue and palate) collected in a fixed sequence of tastant flavors (same for each session) and the assigned test beverage intervention (different for each session)
Conditions Studied
Interventions
- OTHER Beverage
Study Locations (1)
New York
- Gatorade Sports Science Institute - Valhalla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2025-03-24 |
| Est. Completion | 2025-06-29 |
| Phase | NA |
What NCT06933290 shows while recruiting
NCT06933290 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Taste Perception appearing as the primary indexed condition, and to 1 intervention - of which Beverage is the first listed.
NCT06933290 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06933290 about?
NCT06933290 is a clinical study titled "Effect of Flavored, Carbonated Drinks on Salivary Flow, Salivary Composition, and Taste Perceptions". To determine the effect of flavored, carbonated drinks on salivary flow rate, saliva composition, and taste perceptions compared with control drinks (water, carbonated water, non-carbonated)
What is the current status of trial NCT06933290?
This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2025-03-24. Estimated completion is 2025-06-29.
What conditions does trial NCT06933290 study?
This clinical trial studies the following conditions: Taste Perception, Saliva Production.
What interventions are being tested in trial NCT06933290?
The interventions under investigation include: Beverage (OTHER).
Who is sponsoring clinical trial NCT06933290?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06933290 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Taste Perception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06933290's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI